INGR
Ingredion Incorporated112.24
-0.55-0.49%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Argo details justify flat NA outlook.
Q&A unpacked Argo's stubborn Q4 $16 million hit and full-year $40 million drag, with Q1 challenges lingering into cold January but back-half recovery anticipated—yet manufacturing inflation leaves F&I U.S./Canada OI flat. Texture & Healthful solutions comprise 40% of revenue at 5% higher margins, signaling ASP upside despite tapioca pass-throughs. LatAm food volumes grew 3% in Mexico amid brewing weakness, fueling grind diversification to confectionery. Protein fortification surged 40% on GLP-1 demand, fully contracted for 2026. Inflation offsets Argo gains. Watch Argo stabilization and THS pricing power.
Key Stats
Market Cap
7.20BP/E (TTM)
11.19Basic EPS (TTM)
10.03Dividend Yield
0.03%Recent Filings
8-K
Ingredion names interim CFO
Ingredion elected Jason Payant as Interim CFO effective April 1, 2026, succeeding James D. Gray who resigned March 31. Payant, a 14-year company veteran, continues as VP Finance for Global Texture & Healthful Solutions while earning $25,000 monthly extra. No related arrangements or conflicts disclosed. Smooth internal transition.
8-K
Board refresh: out Kenny, in Talbot
Ingredion's board loses veteran director Gregory B. Kenny, who retires effective March 23, 2026, after 21 years with no disagreements noted. Siobhán Talbot, ex-CEO of Glanbia plc, joins April 1, 2026, as NYSE-independent director with nutrition and audit expertise. Standard retainers apply. Smooth transition.
10-K
FY2025 results
Ingredion closed FY2025 with net sales of $7.2B, down 3% y/y from lower volumes and price mix reflecting reduced corn costs, yet operating income rose 15% to $1.0B as gross margins expanded to 25% from cost efficiencies. T&HS drove momentum with 1% sales growth and 16% operating income gains from volume and input savings, while F&II-LATAM eked out 2% income growth despite 4% sales drop; U.S./Canada lagged with 7% sales decline and 16% income fall from volumes and plant issues. Q4 repurchases totaled 796K shares at ~$111 avg, leaving $7.4B authorized through 2028, bolstering liquidity at $3.9B. Strong cash from ops fell to $944M on working capital use. Consumer shifts to 'cleaner' ingredients threaten demand.
8-K
Zallie named Chairman
Ingredion's Board appointed CEO James P. Zallie as Chairman on February 9, 2026, after Gregory B. Kenny resigned from the non-executive Chairman role he'd held since August 1, 2018. Kenny stays on the Board. Independent directors named Victoria J. Reich Lead Director. Leadership consolidates at the top.
8-K
Record EPS despite U.S. setbacks
Ingredion posted record 2025 full-year results with reported EPS of $11.18, up from $9.71, fueled by Texture & Healthful Solutions growth and LATAM gains, yet offset by U.S./Canada operational woes. Cash from operations hit $944 million; returned $435 million to shareholders. Guides 2026 EPS to $11.00-$11.80. U.S. recovery lags.
IPO
Website
Employees
Sector
Industry
ABVE
Above Food Ingredients Inc.
1.83+0.07
ADM
Archer-Daniels-Midland Company
57.98-2.22
ARHUF
AAK AB
27.50+0.00
CAG
ConAgra Brands, Inc.
17.74-0.20
DAR
Darling Ingredients Inc.
35.03-1.16
GIS
General Mills, Inc.
47.02-0.04
GLUC
Glucose Health, Inc.
0.14+0.00
NPRFF
NEPRA FOODS INC.
0.10+0.00
SENEA
Seneca Foods Corp.
110.67-0.92
WLMIF
Wilmar International, Ltd.
2.07-0.28